24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
08/02/2019
Barcelona Synchrotron Park’s #10YearChallenge
01/02/2019
Eurecat, a provider of innovative technologies
25/01/2019
ALBA Synchrotron’s expertise involved in the design of two scientific facilities
18/01/2019
Stradivarius will launch perfumes
11/01/2019
Graphene-based implant developed by IMB and ICN2 on UAB campus records brain activity
03/01/2019
CREAF: 30 years in environmental sciences